Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy Yumeng Wei et al, 2017 CrossRef
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma Yuji Takeyama et al, 2018, Int J Clin Oncol CrossRef
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression Se Kim et al, 2018, IJMS CrossRef
Modern possibilities of organ-preserving treatment of patients with muscle-invasive bladder cancer Vladimir J. Startsev et al, 2019, Urolog vedom CrossRef
Pseudoprogression or unexpected favorable response to third-line therapy Adriana Soares et al, 2020, Porto Biomedical Journal CrossRef
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium Giovanni Schinzari et al, 2018, Oncotarget CrossRef
Use of oral paclitaxel for the treatment of bladder tumors in dogs Hyung-Kyu CHAE et al, 2020, J. Vet. Med. Sci. CrossRef
Review of Curcumin Physicochemical Targeting Delivery System
Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy Qinghai Zeng et al, 2018, Clin Cancer Res CrossRef
ABT-751 Induces Multiple Anticancer Effects in Urinary Bladder Urothelial Carcinoma-Derived Cells: Highlighting the Induction of Cytostasis through the Inhibition of SKP2 at Both Transcriptional and Post-Translational Levels Seyedeh Zahra Dehghanian et al, 2021, IJMS CrossRef
Emerging agents for the treatment of metastatic urothelial cancer Whi-An Kwon et al, 2021, Investig Clin Urol CrossRef
Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin Susanne Deininger et al, 2021, Cancers CrossRef
Medical Image Diagnostic Value of Computed Tomography for Bladder Tumors Lin Li et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework Songyun Zhao et al, 2023, Front. Endocrinol. CrossRef
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma Nataliya Mar et al, 2023, Cancers CrossRef
TiO2 Nanoparticles in Cancer Therapy as Nanocarriers in Paclitaxel’s
Delivery and Nanosensitizers in Phototherapies and/or Sonodynamic
Therapy Fernanda M.P. Tonelli et al, 2023, CPB CrossRef
A ‘golden’ alternative for prevention of cisplatin nephrotoxicity in bladder cancer Yoray Sharon et al, 2023, Cancer Nano CrossRef
Analysis of long non-coding RNAs associated with disulfidptosis for prognostic signature and immunotherapy response in uterine corpus endometrial carcinoma Bohan Li et al, 2023, Sci Rep CrossRef
Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma Yao Zhou et al, 2023, Front. Immunol. CrossRef
Disulfidptosis-related classification patterns and tumor microenvironment characterization in skin cutaneous melanoma Li Yang et al, 2023, Melanoma Management CrossRef
Systemic treatment options in bladder cancer Rahul Ravind et al, 2018, Cancer Res Stat Treat CrossRef
A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma Kai Xie et al, 2024, CBM CrossRef
Gold nanoparticles for safe delivery of cisplatin Yoray Sharon et al, 2024 CrossRef
Therapeutic and prognostic effect of disulfidptosis-related genes in lung adenocarcinoma Changshuan Li et al, 2024, Heliyon CrossRef
Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study Xi Chen et al, 2023 CrossRef
Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity Ruanruan Yang et al, 2024, Front. Immunol. CrossRef